Ledger.Open graph →
SEC Form D · Amendment · filed October 4, 2013

Urigen Pharmaceuticals, Inc

Offering
$856K
Sold
$856K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Dan Vickery · Wilmington, DEExec · DirectorC. L. Parsons · Wilmington, DEDirectorMichael Dearing · San Francisco, CAExec · DirectorAlex Bouzari · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗